Literature DB >> 15243068

Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period.

Lukasz Naumiuk1, Anna Baraniak, Marek Gniadkowski, Beata Krawczyk, Bartosz Rybak, Ewa Sadowy, Alfred Samet, Józef Kur.   

Abstract

The history of the Serratia marcescens population in two hospitals in Danzig, Poland, over a 5-year period was analyzed in a study that combined MIC evaluation, typing by randomly amplified polymorphic DNA (RAPD) analysis and pulsed-field gel electrophoresis, and analysis of extended-spectrum beta-lactamases (ESBLs). We analyzed 354 isolates collected from 341 patients in two teaching hospitals in Danzig, Poland, from 1996 to 2000. The antimicrobial susceptibility profiles varied greatly, and for resistance to newer beta-lactams, probable AmpC cephalosporinase derepression and ESBL production occurred in about 23 and 19% of the isolates, respectively. RAPD typing, by which 69 types were discerned altogether, revealed a high degree of clonal diversity among the populations. However, the four most prevalent types were highly predominant, grouping approximately 71% of the isolates studied. These clones were observed in the two hospitals and were strong contributors to both outbreaks and the background of endemicity of the S. marcescens infections. Some of the strains that were not so widely spread (12 RAPD types; approximately 14% of the isolates) were responsible for several smaller outbreaks, and the remaining isolates represented unique RAPD types (53 types; approximately 15% of the isolates) and were probably sporadic introductions from other environments. ESBLs were identified in several different clones, and some of these had most likely already been introduced into the hospitals as ESBL producers, whereas the others acquired the ESBL-encoding genes from other enterobacterial strains in these environments. The CTX-M-3 enzyme, which is widely observed in Poland, was the most common ESBL type among the S. marcescens isolates, followed by TEM-47 and SHV-5. The complex epidemiology of ESBLs, especially in 1999 and 2000, must have arisen from the introduction of ESBL producers from other centers, their clonal dissemination, and the constant penetration of the S. marcescens populations with plasmids with ESBL genes. Multiple S. marcescens isolates were obtained from 11 patients, who probably represented both patients with recolonizations and reinfections and patients with recurrences of infections with the evolution of the strain's susceptibility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243068      PMCID: PMC446320          DOI: 10.1128/JCM.42.7.3108-3116.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Temporally overlapping nosocomial outbreaks of Serratia marcescens infections: an unexpected result revealed by pulsed-field gel electrophoresis.

Authors:  H Peltroche-Llacsahuanga; R Lütticken; G Haase
Journal:  Infect Control Hosp Epidemiol       Date:  1999-06       Impact factor: 3.254

2.  Investigation of a nosocomial outbreak due to Serratia marcescens in a maternity hospital.

Authors:  P Berthelot; F Grattard; C Amerger; M C Frery; F Lucht; B Pozzetto; P Fargier
Journal:  Infect Control Hosp Epidemiol       Date:  1999-04       Impact factor: 3.254

3.  A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. The French Study Group.

Authors:  C De Champs; D Sirot; C Chanal; R Bonnet; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

4.  Epidemiology and susceptibility of serratia marcescens in a large general hospital over an 8-year period.

Authors:  A Hejazi; H M Aucken; F R Falkiner
Journal:  J Hosp Infect       Date:  2000-05       Impact factor: 3.926

5.  Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan.

Authors:  J J Yan; W C Ko; S H Tsai; H M Wu; Y T Jin; J J Wu
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

6.  An outbreak of multiply resistant Serratia marcescens: the importance of persistent carriage.

Authors:  S Knowles; C Herra; E Devitt; A O'Brien; E Mulvihill; S R McCann; P Browne; M J Kennedy; C T Keane
Journal:  Bone Marrow Transplant       Date:  2000-04       Impact factor: 5.483

7.  Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital.

Authors:  A Pałucha; B Mikiewicz; W Hryniewicz; M Gniadkowski
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

8.  Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases.

Authors:  M Gniadkowski; I Schneider; R Jungwirth; W Hryniewicz; A Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

9.  A novel complex mutant beta-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum beta-lactamase-producing Klebsiellae.

Authors:  J Fiett; A Pałucha; B Miaczyńska; M Stankiewicz; H Przondo-Mordarska; W Hryniewicz; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

10.  SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains.

Authors:  A M Queenan; C Torres-Viera; H S Gold; Y Carmeli; G M Eliopoulos; R C Moellering; J P Quinn; J Hindler; A A Medeiros; K Bush
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

View more
  9 in total

1.  Prevalence of derepressed ampC mutants and extended-spectrum beta-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12.

Authors:  Jungmin Kim; Yu-Mi Lim
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 2.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Population-based laboratory surveillance for Serratia species isolates in a large Canadian health region.

Authors:  K B Laupland; M D Parkins; D B Gregson; D L Church; T Ross; J D D Pitout
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-25       Impact factor: 3.267

4.  Global population structure of the Serratia marcescens complex and identification of hospital-adapted lineages in the complex.

Authors:  Tomoyuki Ono; Itsuki Taniguchi; Keiji Nakamura; Debora Satie Nagano; Ruriko Nishida; Yasuhiro Gotoh; Yoshitoshi Ogura; Mitsuhiko P Sato; Atsushi Iguchi; Kazunori Murase; Dai Yoshimura; Takehiko Itoh; Ayaka Shima; Damien Dubois; Eric Oswald; Akira Shiose; Naomasa Gotoh; Tetsuya Hayashi
Journal:  Microb Genom       Date:  2022-03

Review 5.  Serratia marcescens Infections in Neonatal Intensive Care Units (NICUs).

Authors:  Maria Luisa Cristina; Marina Sartini; Anna Maria Spagnolo
Journal:  Int J Environ Res Public Health       Date:  2019-02-20       Impact factor: 3.390

6.  Exogenous lipoid pneumonia associated with oil-based oral and nasal products.

Authors:  Sabrina H M Yeung; Lianne E Rotin; Kevin Singh; Robert Wu; Matthew B Stanbrook
Journal:  CMAJ       Date:  2021-10-12       Impact factor: 8.262

7. 

Authors:  Sabrina H M Yeung; Lianne E Rotin; Kevin Singh; Robert Wu; Matthew B Stanbrook
Journal:  CMAJ       Date:  2021-12-13       Impact factor: 8.262

8.  Genome evolution and plasticity of Serratia marcescens, an important multidrug-resistant nosocomial pathogen.

Authors:  Atsushi Iguchi; Yutaka Nagaya; Elizabeth Pradel; Tadasuke Ooka; Yoshitoshi Ogura; Keisuke Katsura; Ken Kurokawa; Kenshiro Oshima; Masahira Hattori; Julian Parkhill; Mohamed Sebaihia; Sarah J Coulthurst; Naomasa Gotoh; Nicholas R Thomson; Jonathan J Ewbank; Tetsuya Hayashi
Journal:  Genome Biol Evol       Date:  2014-08       Impact factor: 3.416

9.  Recent independent emergence of multiple multidrug-resistant Serratia marcescens clones within the United Kingdom and Ireland.

Authors:  Danesh Moradigaravand; Christine J Boinett; Veronique Martin; Sharon J Peacock; Julian Parkhill
Journal:  Genome Res       Date:  2016-07-18       Impact factor: 9.043

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.